Potassium sodium hydrogen citrate

DB16585InvestigationalSmall molecule

Potassium sodium hydrogen citrate is a urine alkalinizing agent indicated in the treatment and prevention of uric acid, oxalate, phosphate, and cystine stones. A medication used to treat and prevent kidney stones and other stones.

Formula / weight: C₁₂H₁₂K₃Na₃O₁₅ · 582.477 g/mol (avg)
Also known as: Hexapotassium hexasodium pentacitrate hydrate · Hexapotassium hexasodium pentacitrate hydrate complex · Sodium potassium hydrogen citrate · Uralyt-U

Resolves to

Compound

UNIIX6T6YN87SUCAS55049-48-4

Structure

InChIKeyIYKMDRMCUIFHRA-UHFFFAOYSA-HSMILES[Na+].[Na+].[Na+].[K+].[K+].[K+].[H]O[H].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

What you can answer from here — as of March 06, 2025

5Clinical trialsPhase, status and sponsor resolved per trial

3Structured indicationsCondition, population, route and combination as fields, not prose

8ContraindicationsEach with its own population and attribute set

3Marketed productsAcross 2 countries and 2 labellers

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Potassium sodium hydrogen citrate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account